AGIOS PHARMACEUTICALS INC. - COMMON STOCK

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

17 Apr 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

09 Apr 2025 09:57:01 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

08 Apr 2025 13:50:06 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

07 Apr 2025 09:45:27 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

04 Apr 2025 09:58:04 By NetDania Notify

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

01 Apr 2025 13:49:16 By NetDania Notify

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

05 Mar 2025 17:52:45 By Nasdaq GlobeNewswire

Agios to Present at Upcoming Investor Conferences

04 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

20 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

13 Feb 2025 06:31:00 By Nasdaq GlobeNewswire

Agios’ Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint

13 Feb 2025 06:30:00 By Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

06 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

13 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia

08 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

03 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease

18 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

08 Dec 2024 12:40:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

11 Nov 2024 09:45:31 By NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

08 Nov 2024 09:55:39 By NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

07 Nov 2024 14:59:27 By NetDania Notify